Receiveable Turnover: An accounting measure used to quantify a firm's effectiveness in extending credit as well as collecting debts. Calculated as: Total Revenues / Accounts Receivable
Aytu BioPharma Inc. (AYTU) had Receiveable Turnover of 0.60 for the most recently reported fiscal quarter, ending 2024-03-31.
| Income Statement Financials | |
$17.99M |
|
$-2.89M |
|
$6.30M |
|
$11.69M |
|
$20.46M |
|
$-2.46M |
|
$-0.18M |
|
$-2.64M |
|
$-2.64M |
|
$-2.89M |
|
$-2.89M |
|
$-2.89M |
|
$-2.89M |
|
$-2.46M |
|
$-0.38M |
|
5.53M |
|
5.53M |
|
$-0.52 |
|
$-0.52 |
|
| Balance Sheet Financials | |
$71.13M |
|
$0.97M |
|
$57.73M |
|
$128.86M |
|
$83.69M |
|
-- |
|
$14.40M |
|
$98.09M |
|
$30.78M |
|
$-23.30M |
|
$30.78M |
|
5.57M |
|
| Cash Flow Statement Financials | |
$-0.60M |
|
$-0.29M |
|
$-2.33M |
|
$22.98M |
|
$19.76M |
|
$-3.23M |
|
$2.56M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.85 |
|
-- |
|
-- |
|
-- |
|
0.54 |
|
64.99% |
|
-13.69% |
|
-13.69% |
|
-- |
|
-14.68% |
|
-16.05% |
|
$-0.60M |
|
-- |
|
-- |
|
-- |
|
0.14 |
|
0.48 |
|
|
Receiveable Turnover |
0.60 |
149.68 |
|
-9.38% |
|
12.39% |
|
-2.24% |
|
-9.38% |
|
$5.53 |
|
$-0.11 |
|
$-0.11 |
|